Globe Life (NYSE:GL) Reaches New 52-Week High – Here’s Why

Globe Life Inc. (NYSE:GL)’s stock price reached a new 52-week high during trading on Wednesday . The company traded as high as $156.69 and last traded at $156.21, with a volume of 12021 shares trading hands. The stock had previously closed at $154.14.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on the stock. Keefe, Bruyette & Woods reaffirmed a “moderate buy” rating and issued a $168.00 price target on shares of Globe Life in a report on Thursday, March 26th. Weiss Ratings lowered Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a report on Monday, April 27th. Truist Financial raised their price objective on Globe Life from $180.00 to $185.00 and gave the stock a “buy” rating in a research report on Friday, April 24th. JPMorgan Chase & Co. boosted their target price on Globe Life from $180.00 to $181.00 and gave the stock an “overweight” rating in a research note on Thursday, February 5th. Finally, Piper Sandler raised Globe Life to a “strong-buy” rating in a research report on Thursday, April 2nd. Two research analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, Globe Life has an average rating of “Buy” and a consensus price target of $172.67.

Globe Life Stock Performance

The company has a market cap of $12.11 billion, a PE ratio of 10.67 and a beta of 0.50. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.39. The firm’s 50-day simple moving average is $144.52 and its two-hundred day simple moving average is $140.12.

Globe Life (NYSE:GL) last posted its quarterly earnings results on Wednesday, April 22nd. The company reported $3.43 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.46 by ($0.03). Globe Life had a return on equity of 21.30% and a net margin of 19.38%.The company had revenue of $1.56 billion during the quarter, compared to analysts’ expectations of $1.56 billion. During the same period in the prior year, the business posted $3.07 EPS. The company’s quarterly revenue was up 5.3% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. As a group, research analysts anticipate that Globe Life Inc. will post 15.53 earnings per share for the current fiscal year.

Globe Life Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Monday, July 6th will be paid a $0.33 dividend. The ex-dividend date is Monday, July 6th. This represents a $1.32 dividend on an annualized basis and a yield of 0.9%. Globe Life’s dividend payout ratio (DPR) is 9.13%.

Insider Activity at Globe Life

In other news, CEO Frank M. Svoboda sold 12,500 shares of the firm’s stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $144.78, for a total value of $1,809,750.00. Following the completion of the transaction, the chief executive officer directly owned 35,868 shares in the company, valued at $5,192,969.04. This trade represents a 25.84% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Robert Edward Hensley sold 712 shares of Globe Life stock in a transaction dated Wednesday, February 25th. The stock was sold at an average price of $142.59, for a total value of $101,524.08. Following the sale, the executive vice president directly owned 8,580 shares of the company’s stock, valued at $1,223,422.20. This trade represents a 7.66% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 121,470 shares of company stock worth $17,988,368 in the last quarter. 2.11% of the stock is owned by insiders.

Hedge Funds Weigh In On Globe Life

A number of institutional investors have recently bought and sold shares of GL. Compound Planning Inc. boosted its holdings in shares of Globe Life by 4.3% in the 4th quarter. Compound Planning Inc. now owns 1,968 shares of the company’s stock valued at $275,000 after acquiring an additional 82 shares during the last quarter. Root Financial Partners LLC raised its holdings in shares of Globe Life by 23.3% during the first quarter. Root Financial Partners LLC now owns 439 shares of the company’s stock worth $61,000 after purchasing an additional 83 shares during the last quarter. Transcend Capital Advisors LLC lifted its position in Globe Life by 3.9% during the fourth quarter. Transcend Capital Advisors LLC now owns 2,265 shares of the company’s stock valued at $317,000 after purchasing an additional 84 shares during the period. Natural Investments LLC boosted its holdings in Globe Life by 2.6% in the fourth quarter. Natural Investments LLC now owns 3,452 shares of the company’s stock valued at $482,000 after purchasing an additional 87 shares during the last quarter. Finally, Parallel Advisors LLC boosted its holdings in Globe Life by 5.6% in the fourth quarter. Parallel Advisors LLC now owns 1,651 shares of the company’s stock valued at $231,000 after purchasing an additional 87 shares during the last quarter. 81.61% of the stock is owned by hedge funds and other institutional investors.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.